The treatment schedule and historical naming process of Behçet disease

JEADV 2007, 21, 392–435 © 2006 European Academy of Dermatology and Venereology 427 sequels were still present. In conclusion, skin coverage with Veloderm® on TEN provided a bacteriological barrier that prevented fluid and protein loss, reduced pain, and ensured undisturbed healing without adverse side-effects; Veloderm® showed a remarkable efficacy regarding both time and quality of healing. D Melandri Burn Intensive Care Unit, Bufalini Hospital, Viale Chirotti 286, I-47023 Cesana, Italy, tel. +39 0547 352727; fax +39 0547 352718; E-mail: davmelan@tin.it

[1]  D. Melandri,et al.  Use of a new hemicellulose dressing (Veloderm) for the treatment of split-thickness skin graft donor sites A within-patient controlled study. , 2006, Burns : journal of the International Society for Burn Injuries.

[2]  S. Androudi.  Current concepts in the etiology and treatment of Behçet disease. , 2006, Survey of ophthalmology.

[3]  C. Evereklioglu,et al.  Managing the symptoms of Behçet’s disease , 2004, Expert opinion on pharmacotherapy.

[4]  B. Otlu,et al.  Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity , 2002, The British journal of dermatology.

[5]  H. Er,et al.  Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. , 2002, Mediators of inflammation.

[6]  Y. Turkoz,et al.  Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker? , 2002, Journal of the American Academy of Dermatology.

[7]  J. Tschopp,et al.  Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. , 1998, Science.

[8]  A. Munster,et al.  Toxic Epidermal Necrolysis Syndrome: Mortality Rate Reduced with Early Referral to Regional Burn Center , 1998, Plastic and reconstructive surgery.

[9]  N. Dilşen.  History and development of Behçet's disease. , 1996, Revue du rhumatisme.

[10]  G. Shires,et al.  Improved Burn Center Survival of Patients with Toxic Epidermal Necrolysis Managed without Corticosteroids , 1986, Annals of surgery.

[11]  Hulusi Behçet.  SOME OBSERVATION ON CLINICAL PICTURE OF THE SO-CALLED TRIPLE SYMPTOM COMPLEX , 1940 .

[12]  H. Behcet.  UBER REZIDIVERENDE APHTHOSE DURCH EIN VIRUS VERURSACHTE GESCHWURE AM MUND, AM AUGE UND AN DEN GENITALIEN , 1937 .